09.00-10.05 LUNG CANCER

09:00 – 09:15 Búsqueda de marcadores tempranos en sangre
Searching for early markers in blood
Dra. Eloisa Jantus, Hospital General Universitario de Valencia

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/1.-Dra.-Eloisa-Jantus.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

10.05-11.10 PROSTATE CANCER

10: 05 – 10:20 AR-V7. Significado clínico en pacientes con cáncer de próstata metastásico
AR-V7. Clinical signifi cance in metastatic prostate cancer patients
Dr. Emmanuel Antonarakis, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Baltimore, Maryland, USA

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/1.-Dr.-Emmanuel-Antonarakis.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]


10:20 – 10:35 ctDNA como guía para el tratamiento de cáncer de próstata con inhibidores de PARP
ctDNA as a guide for the treatment of prostate cancer with PARP inhibitors
Dr. Joaquín Mateo, Vall d’Hebron Institut d’Oncologia – VHIO. Barcelona

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/2.-Dr.-Joaquin-Mateo.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]


10:35 – 10:50 Ensayos clínicos activos para validar el uso clínico de biopsias líquidas en cáncer de próstata
Ongoing clinical trials for the validation of liquid biopsy in prostate cancer
Dr. José Ángel Arranz, Hospital General Universitario Gregorio Marañón. Madrid

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/3.-Dr.-Jose-Angel-Arranz.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

11.40-12.45 LIQUID BIOPSY AND TUMOR HETEROGENEITY

11:40 – 11:55 Análisis evolutivo de genomas de células individuales
Evolutionary analysis of single-cell genomes
Dr. David Posada, Universidad de Vigo

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/1.-Dr.-David-Posada.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]


12:10 – 12:25 Manejo de la heterogeneidad tumoral en clínica
Clinical management of tumor heterogeneity
Dr. Emilio Alba, Hospital Universitario Virgen de la Victoria. Málaga

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/3.-Dr.-Emilio-Alba.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

12.45-13.45 ROUND TABLE: RIVAL OR COMPLEMENTARY IN SEARCH OF A PRECISION MEDICINE?

12:45 – 13:05 Ronda 1: Biopsia de tejido versus biopsia líquida
Round 1: Tissue biopsy versus liquid biopsy
Dra. Mar Varela, Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, Barcelona

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/1.1.-Dra.-Mar-Varela.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

Dr. César A. Rodríguez, Hospital Clínico Universitario, Salamanca

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/1.2.-Dr.-Cesar-A.-Rodriguez.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]


13:05 – 13:25 Ronda 2: ctDNA vs CTCs
Round 2: ctDNA vs CTCs
Dr. Roberto Piñeiro, Unidad mixta ROCHE CHUS. Complejo Hospitalario Universitario de Santiago

[su_button url=”https://simposiobiopsialiquida.com/wp-content/uploads/2018/01/2.2.-Dr.-Roberto-Piñeiro.pdf” target=”blank” background=”#41b9e3″]Presentation[/su_button]

Passatge Batlló, 15
Barcelona

T. +34 93 451 17 24
F. 93 451 43 66

info@tacticsmd.net
www.tacticsmd.net


San Francisco Hotel Monumento
Campillo de San Francisco, 3
Santiago de Compostela
www.sanfranciscohm.com